These GWAS have identified 32 major histocompatibility complex (MHC) variants and over 200 non-MHC candidate variants associated with MS, with the haplotype HLA-DRB1*15:01 (MHC, chromosome 6p21.3) having the most substantial impact [10, 12]. This evidence concerns the gene HLA-C and myeloid sarcoma.